BIOPHYTIS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.78 EUR | -2.45% |
|
-1.83% | -61.76% |
| May. 14 | Biophytis unveils design for obesity study | CF |
| May. 14 | Biophytis SA Announces the Design of its Phase 2 OBA Clinical Study in Obesity | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | - | Sales 2025 * | 4.8M 5.21M | Capitalization | 2.29M 2.49M |
|---|---|---|---|---|---|
| Net income 2024 * | -19M -20.64M | Net income 2025 * | -16M -17.38M | EV / Sales 2024 * | - |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.48 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 22 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.58% |
More Fundamentals
* Assessed data
| 1 day | -2.45% | ||
| 1 week | -1.83% | ||
| Current month | -7.14% | ||
| 1 month | -15.22% | ||
| 3 months | -54.65% | ||
| 6 months | -70.00% | ||
| Current year | -61.76% |
1 week
0.75
0.82
1 month
0.741.08
Current year
0.742.24
1 year
0.7412.80
3 years
0.74423.80
5 years
0.741 092.00
10 years
0.747 720.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-20 | 0.78 | -2.45% | 18 311 |
| 24-05-17 | 0.7996 | +1.04% | 13,125 |
| 24-05-16 | 0.7914 | -1.08% | 29,813 |
| 24-05-15 | 0.8 | +2.56% | 44,528 |
| 24-05-14 | 0.78 | -1.83% | 47,587 |
Real-time Euronext Paris, May 20, 2024 at 11:35 am EDT
More quotes
Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.
The company is located in Paris, France and Cambridge, Massachusetts.
Calendar
2024-10-28
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -61.76% | 2.49M | |
| +9.88% | 115B | |
| +11.93% | 106B | |
| -2.59% | 21.96B | |
| -12.36% | 21.87B | |
| -5.29% | 19.21B | |
| -3.83% | 18.08B | |
| -38.57% | 17.71B | |
| +7.12% | 14.32B | |
| +34.75% | 12.42B |
- Stock Market
- Equities
- ALBPS Stock
